Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size

Shared Decision Making for Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
Technische Universität München
ClinicalTrials.gov Identifier:
NCT00220870
First received: September 15, 2005
Last updated: April 7, 2010
Last verified: April 2010
History of Changes
  Purpose
The impact of a decision aid for inpatients with schizophrenia on perceived involvement and compliance is studied in comparison with routine care.

Condition Intervention
Schizophrenia
 Behavioral: Decision aid

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Shared Decision Making in the Therapy of Schizophrenia

Resource links provided by NLM:

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Further study details as provided by Technische Universität München:

Primary Outcome Measures:
  • Patients' compliance

Secondary Outcome Measures:
  • perceived involvement in medical decisions
  • rehospitalizations
  • QoL
Study Start Date: January 2003
Estimated Study Completion Date: August 2005
Detailed Description:
to follow
  Eligibility
Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • schizophrenia (ICD10)
  • age 18 - 65 years
  • inpatients

Exclusion Criteria:

  • mental retardation
  • no informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00220870

Locations
Germany
Psychiatric Department, TU München
München, Germany, 81675
Sponsors and Collaborators
Technische Universität München
Investigators
Study Chair: Werner Kissling, MD TU München, Psychiatric Department
  More Information

Additional Information:
Related Info  This link exits the ClinicalTrials.gov site

ClinicalTrials.gov Identifier: NCT00220870     History of Changes
Other Study ID Numbers: 217-43794-5/9 
Study First Received: September 15, 2005
Last Updated: April 7, 2010
Health Authority: Germany: Ethics Commission

Keywords provided by Technische Universität München:
schizophrenia
shared decision making
compliance
maintenance therapy

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 28, 2016